| Literature DB >> 34675556 |
Dagninet Alelign1, Gemechu Ameya2, Munira Siraj1.
Abstract
BACKGROUND: Ascitic fluid plays a critical role in the microbiological diagnosis of peritonitis. Drug-resistant bacterial infection of the peritoneal cavity is becoming a public health threat. However, data on bacterial profile and antimicrobial-resistant pattern of isolates from the ascitic fluid are scarce. Thus, this study was aimed to assess drug-resistant bacteriological profiles and factors associated with peritonitis in southern Ethiopia.Entities:
Keywords: antimicrobial resistance; ascitic fluid; bacteriological profile; peritoneal effusion; southern Ethiopia
Year: 2021 PMID: 34675556 PMCID: PMC8502028 DOI: 10.2147/IDR.S335103
Source DB: PubMed Journal: Infect Drug Resist ISSN: 1178-6973 Impact factor: 4.003
Socio-Demographic Characteristics of Study Participants
| Variables | Categories | Frequency | Percentage (%) (n=147) |
|---|---|---|---|
| Sex | Male | 91 | 58.3 |
| Female | 56 | 41.7 | |
| Age in years | ≤ 25 | 9 | 6.1 |
| 26–45 | 45 | 30.6 | |
| 46–65 | 70 | 47.6 | |
| ≥66 | 23 | 15.6 | |
| Residence | Urban | 58 | 39.4 |
| Rural | 89 | 60.6 | |
| Educational status | Illiterate | 10 | 6.8 |
| Primary | 52 | 35.2 | |
| Secondary | 47 | 32 | |
| Diploma & above | 38 | 26 | |
| Occupation | Farmer | 36 | 24.5 |
| House wife | 23 | 15.6 | |
| Merchant | 43 | 29.3 | |
| Student | 14 | 9.5 | |
| Employee | 31 | 21.1 |
Figure 1Distribution of isolated bacteria from ascitic fluids of study participant.
Bivariate and Multivariable Logistic Regressions of Factors Associated to Bacterial Peritonitis
| Variables | Culture Results | COR [95% CI] | AOR [95% CI] | P-value | |
|---|---|---|---|---|---|
| Negative | Positive | ||||
| No (%) | No (%) | ||||
| Gender | |||||
| Male | 78(85.7) | 13(14.3) | 1 | 1 | |
| Female | 41(73.2) | 15(16.8) | 2.195[0.954–5.05] | 1.583[0.530–4.727] | 0.411 |
| Age in years | |||||
| ≤25 | 6(66.7) | 3(33.3) | 1 | 1 | |
| 26–45 | 41(91) | 4(9%) | 0.195[0.035–1.095] | 0.430[0.024–7.587] | 0.564 |
| 46–65 | 55(78.6) | 15(21.4) | 0.545[0.122–2.442] | 0.883[0.059–13.32] | 0.929 |
| ≥66 | 17(74) | 6(26) | 0.706[0.133–3.748] | 1.165[0.05 9–22.95] | 0.920 |
| Hospitalization | |||||
| ≤ 7 days admitted | 82(90) | 9 (10) | 1 | 1 | |
| >7 days admitted | 37(66) | 19 (34) | 4.679[1.935–11.314] | 8.990[2.755–29.342] | 0.001 |
| History of Abdominal surgery | |||||
| Yes | 22(59.5) | 15(40.5) | 5.087[2.121–12.205] | 8.724[2.688–28.314] | 0.001 |
| No | 97(88.2) | 13(11.8) | 1 | 1 | |
| Cirrhosis | |||||
| Positive | 45(70.3) | 19(29.7) | 3.472[1.447–8.331] | 2.751[1.109–6.822] | 0.029 |
| Negative | 74 (89.2) | 9(10.8) | 1 | ||
| Drinking alcohol | |||||
| Yes | 33(66) | 17(34) | 4.028[1.708–9.499] | 5.802[1.948–17.285] | 0.002 |
| No | 86(88.7) | 11(11.3) | 1 | 1 | |
| Body Mass Index (BMI) Kg/m2 | |||||
| <18 | 5(38.5) | 8(61.5) | 6.400[0.947–43.234] | 7.540 [0.634–89.704] | 0.110 |
| 18.5–24.9 | 106(85.5) | 18(14.5) | 0679[0.133–3.460] | 0.693[0.082–5.874] | 0.737 |
| >25 | 8(80) | 2(20) | 1 | 1 | |
Abbreviations: BMI, body mass index; Kg, kilogram; M, meter; COR, crude odds ratio; AOR, adjusted odds ratio; CI, confidence interval.
Antimicrobial Resistant Pattern of Gram Negative Bacteria Isolates from Ascitic Fluids
| Antimicrobial Agents Tested | Pattern | Total (n=23) | ||||
|---|---|---|---|---|---|---|
| No. (%) | No. (%) | No. (%) | No. (%) | No. (%) | ||
| AMP | 3(27.3) | 2(33.3) | NA | 1(50) | 6(26) | |
| 0(0) | 0(0) | NA | 0(0) | 0(0) | ||
| 8(72.7) | 4(66.7) | NA | 1(50) | 13(56.5) | ||
| GEN | 8(72.7) | 4(66.7) | 3(75) | 1(50) | 16(69.6) | |
| 0(0) | 0(0) | 0(0) | 0(0) | 0(0) | ||
| 3(27.3) | 2(33.3) | 1(25) | 1(50) | 7(30.4) | ||
| S | 4(36.4) | 3(50) | NA | 1(50) | 8(37.8) | |
| 0(0) | 0(0) | NA | 0(0) | 0(0) | ||
| 7(63.6) | 3(50) | NA | 1(50) | 11(47.8) | ||
| TET | 3(27.3) | 2(33.3) | NA | 1(50) | 6(26) | |
| 1(9.1) | 1(16.7) | NA | 1(50) | 3(13) | ||
| 7(63.6) | 3(50) | NA | 0(0) | 10(43.5) | ||
| DOX | 4(36.4) | 3(50) | NA | 1(50) | 8(37.8) | |
| 0(0) | 0(0) | NA | 0(0) | (0) | ||
| 7(63.6) | 3(50) | NA | 1(50) | 11(47.8) | ||
| CPR | 2(18.2) | 2(33.3) | 1(25) | 0(0) | 5(21.7) | |
| 0(0) | 1(16.7) | 0(0) | 1(50) | 2(8.7) | ||
| 9(81.8) | 3(50) | 3(75) | 1(50) | 16(69.6) | ||
| CFP | 4(36.4) | 2(33.3) | 1(25) | 1(50) | 8(35) | |
| 0(0) | 0(0) | 0(0) | 0(0) | 0(0) | ||
| 7(63.6) | 4(66.7) | 3(75) | 1(50) | 15(65.2) | ||
| CTR | 2(18.2) | 1(16.7) | NA | 0(0) | 3(13) | |
| 0(0) | 0(0) | NA | 0(0) | 0(0) | ||
| 9(81.8) | 5(83.3) | NA | 2(100) | 16(69.6) | ||
| CRX | 3(27) | 2(33.3) | NA | 0(0) | 5(21.7) | |
| 1(9) | 0(0) | NA | 0(0) | 1(4.3) | ||
| 7(64) | 4(66.7) | NA | 2(100) | 13(56.5) | ||
| CFZ | NA | NA | 1(25) | NA | 1(4.3) | |
| NA | NA | 0(0) | NA | 0(0) | ||
| NA | NA | 3(75) | NA | 3(13) | ||
| CHL | 7(63.6) | 2(33.3) | NA | 2(100) | 11(47.8) | |
| 0(0) | 0(0) | NA | 0(0) | 0(0) | ||
| 4(36.4) | 4(66.7) | NA | 0(0) | 8(37.8) | ||
| MER | 8(72.7) | 4(66.7) | 2(50) | 1(50) | 15(65.2) | |
| 1(9.1) | 1(16.7) | 0(0) | 0(0) | 2(8.7) | ||
| 2(18.2) | 1(16.7) | 2(50) | 1(50) | 6(26) | ||
| CXT | 5(45.5) | 2(33.3) | NA | 1(50) | 8(34.8) | |
| 1(9) | 1(16.7) | NA | 1(50) | 3(13) | ||
| 5(45.5) | 3(50) | NA | 0(0) | 8(34.8) | ||
| PIP | NA | NA | 3(75) | NA | 3(13) | |
| NA | NA | 0(0) | NA | 0(0) | ||
| NA | NA | 1(25) | NA | 1(4.3) |
Abbreviations: AM, ampicillin; GEN, gentamicin; S, streptomycin; TET, tetracycline; DOX, doxycycline; CPR, ciprofloxacin; CFP, cefepime; CTR, ceftriaxone; CRX, cefuroxime; CFZ, ceftazidime; CHL, chloramphenicol; MER, meropenem; CXT, cefoxitin; PIP, piperacillin; NA, not applicable; because of CLSI 2018 guide line recommendation; S, sensitive; I, intermediate; R, resistance; spp, species.
Antimicrobial Resistant Pattern of Gram Positive Bacteria Isolates from Ascitic Fluids
| Antimicrobial Agents Tested | Pattern | Total (n=7) | |||
|---|---|---|---|---|---|
| No. (%) | No. (%) | No. (%) | No. (%) | ||
| PEN | 1(25) | 1(50) | 0(0) | 2(28.6) | |
| 0(0) | 0(0) | 0(0) | 0(0) | ||
| 3(75) | 1(50) | 1(100) | 5(71.4) | ||
| GEN | 3(75) | 2(100) | NA | 5(71.4) | |
| 0(0) | 0(0) | NA | 0(0) | ||
| 1(25) | 0(0) | NA | 1(14.3) | ||
| ERY | 2(50) | 2(100) | 1(100) | 5(71.4) | |
| 1(25) | 0(0) | 0(0) | 1(14.3) | ||
| 1(25) | 0(0) | 0(0) | 1(14.3) | ||
| TET | 1(25) | 0(0) | 0(0) | 1(14.3) | |
| 0(0) | 1(50) | 0(0) | 1(14.3) | ||
| 3(75) | 1(50) | 1(100) | 5(71.4) | ||
| DOX | 2(50) | 0(0) | 0(0) | 2(28.6) | |
| 0(0) | 1(50) | 0(0) | 1(14.3) | ||
| 2(50) | 1(50) | 1(100) | 4(57.1) | ||
| CPR | 2(50) | 1(50) | 0(0) | 3(42.9) | |
| 0(0) | 0(0) | 0(0) | 0(0) | ||
| 2(50) | 1(50) | 1(100) | 4(57.1) | ||
| COT | 2(50) | 2(100) | NA | 4(57.1) | |
| 1(25) | 0(0) | NA | 1(14.3) | ||
| 1(25) | 0(0) | NA | 1(14.3) | ||
| CLD | 3(75) | 2(100) | NA | 5(71.4) | |
| 1(25) | 0(0) | NA | 1(14.3) | ||
| 0(0) | 0(0) | NA | 0(0) | ||
| CHL | 1(25) | 0(0) | 0(0) | 1(14.3) | |
| 1(25) | 1(50) | 0(0) | 2(28.6) | ||
| 2(50) | 1(50) | 1(100) | 4(57.1) | ||
| VAN | NA | NA | 0(0) | 0(0) | |
| NA | NA | 0(0) | 0(0) | ||
| NA | NA | 1(100) | 1(14.3) | ||
| CXT | 3(75) | 1(50) | NA | 4(57.1) | |
| 0(0) | 0(0) | NA | 0(0) | ||
| 1(25) | 1(50) | NA | 2(28.6) |
Abbreviations: PEN, penicillin; GEN, gentamicin; ERY, erythromycin; TET, tetracycline; DOX, doxycycline; CPR, ciprofloxacin; COT, cotrimoxazole; CLD, clindamycin; CHL, chloramphenicol; VAN, vancomycin; CXT, cefoxitin; NA, not applicable based on CLSI 2018 guide line recommendation; S, sensitive; I, intermediate; R, resistance; CoNS, coagulase negative Staphylococcus; spp, species.
Multi-Drug Resistant Pattern of Isolated Bacteria from Ascitic Fluids
| Frequency of Isolated Bacteria | Multi-Drug Resistant Isolated Bacteria (%) |
|---|---|
| 5 (45.5) | |
| 2(33.3) | |
| 2(50) | |
| 1(50) | |
| 2(50) | |
| 0 | |
| 1(100) | |
Abbreviations: spp, species; CoNS, coagulase negative Staphylococcus.